Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
IM Cannabis Corp
(CSE:
IMCC
)
3.970
UNCHANGED
Official Closing Price
Updated: 11:35 AM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about IM Cannabis Corp
IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY
August 14, 2024
The company, announced its financial results Wednesday for the second quarter ended June 30, 2024, revealing a 12% year-over-year increase in revenue to CA$14.8 million in the second quarter of 2023....
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now
August 06, 2024
Medical cannabis company IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 2024 ended June 30,...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis Announces Major Share Consolidation Plan: What Investors Need To Know
July 05, 2024
IM Cannabis announces a share consolidation effective July 12, aiming to enhance marketability and streamline shares.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Global Weed Business: Flora Buys Australian Vaporizers As IM Cannabis Doubles Down On Germany
June 05, 2024
Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF) said on Wednesday the sale of Australian Vaporizers Pty Ltd., its wholly owned Australian subsidiary to Flora Growth Corp. (NASDAQ:...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis Doubles Down On Germany Following Legalization Policy Change, Reports YoY Drop In Q1 Gross Profit And Revenue
May 08, 2024
IM Cannabis reported a 13% sequential increase in revenue for the three months ended March 31, 2024, hitting CA$10.7 million ($7.8 million). That is, however, a 4% decrease compared to the same quarter...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity
March 28, 2024
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial and operational results for the year ended Dec. 2023. The Toronto-headquartered medical cannabis company with a focus on...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis Stock Drops On Q2 Earnings, CEO Touts Strategic Decisions That Led To 'Sustainable Profitability'
August 14, 2023
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) reported its second-quarter financial results on Tuesday for the period ending June 30, 2023.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis To Buy Jerusalem-Based Medical Marijuana Pharmacy For $4.9M In Cash And Stock
December 01, 2021
IM Cannabis Corp. (CSE:IMCC), (NASDAQ:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis To Debut WAGNERS Brand In Israel After Receiving Regulatory Approval
November 30, 2021
IM Cannabis Corp. (CSE:IMCC) (NASDAQ:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.